SCHEMBL4876014

SCHEMBL4876014

CCc1nn(-c2ccncc2)c([AsH]c2ccc(Cl)cc2C(=O)OC)c1Br

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNMA1 Q12791 1/20 0.35
ALDH1A1 P00352 3/20 0.35
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
NPY1R P25929 1/20 0.35
NPY2R P49146 1/20 0.35
ABL1 P00519 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33
USP2 O75604 1/20 0.33
MAPK10 P53779 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
CYP46A1 Q9Y6A2 1/20 0.33
CNR1 P21554 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.32
ABCB1 P08183 1/20 0.32
TP53 P04637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4668860 0.80 KCNMA1 (0.38) KCNMA1ALDH1A1KMT2AMEN1KDM4E
SCHEMBL4667518 0.69 KCNMA1 (0.39) KCNMA1ALDH1A1KMT2AMEN1KDM4E
SCHEMBL14600645 0.67 ALDH1A1 (0.41) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL4666092 0.64 ADORA1 (0.46) KDM4E
SCHEMBL10174510 0.62 ABL1 (0.57) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL31511630 0.62 CYP46A1 (0.58) KCNMA1ALDH1A1KMT2AMEN1HPGD
SCHEMBL852809 0.61 ABL1 (0.59) ALDH1A1KMT2AMEN1KDM4EABL1
SCHEMBL10487662 0.60 ABL1 (0.62) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL10598773 0.59 KMT2A (0.45) ALDH1A1KMT2AMEN1KDM4EHPGD
SCHEMBL4160132 0.59 OPRK1 (0.44) ALDH1A1KMT2AMEN1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1928455-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES Bayer Healthcare, LLC (US) 2008-06-11 EP disclosed
WO-2007027842-A1 ANILINOPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES BAYER HEALTHCARE LLC (US) 2007-03-08 WO disclosed